Literature DB >> 1167643

Autonomic dysfunction in botulism B: a clinical report.

G Jenzer, M Mumenthaler, H P Ludin, F Robert.   

Abstract

Nine cases of botulism B with preponderant effects upon cholinergic autonomic innervation are presented. Blurred vision and dry mouth were constant symptoms. Impairment of salivary and lacrimal secretion were detectable for months. In the absence of clinical signs, electromyographic studies did not reveal neuromuscular involvement. Administration of antitoxin in the late course of such cases is not recommended, but guanidine can be used. Doubt is cast upon a new clinical entity called "acute autonomic neuropathy."

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167643     DOI: 10.1212/wnl.25.2.150

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation.

Authors:  David J Keegan; Gerd Geerling; John P Lee; Glen Blake; J Richard Collin; Gordon T Plant
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

Review 2.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

3.  Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation.

Authors:  W P Cheshire
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

4.  Botulinum toxin in the therapy of gustatory sweating.

Authors:  A Schulze-Bonhage; M Schroder; A Ferbert
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

Review 5.  Postganglionic cholinergic dysautonomia with incomplete recovery: a clinical, neurophysiological and immunological case study.

Authors:  R Baron; F Engler
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

6.  Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

Authors:  Agam K Rao; Jeremy Sobel; Kevin Chatham-Stephens; Carolina Luquez
Journal:  MMWR Recomm Rep       Date:  2021-05-07

7.  Acute pandysautonomia and severe sensory deficit with poor recovery. A clinical, neurophysiological and pathological case study.

Authors:  J Fagius; C E Westerberg; Y Olsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-08       Impact factor: 10.154

8.  Long lasting dysautonomia due to botulinum toxin B poisoning: clinical-laboratory follow up and difficulties in initial diagnosis.

Authors:  Anna Potulska-Chromik; Beata Zakrzewska-Pniewska; Elżbieta Szmidt-Sałkowska; Jacek Lewandowski; Maciej Siński; Witold Przyjałkowski; Anna Kostera-Pruszczyk
Journal:  BMC Res Notes       Date:  2013-10-30

9.  Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Authors:  Christelle Mazuet; Christine Legeay; Jean Sautereau; Laurence Ma; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  Genome Biol Evol       Date:  2016-06-13       Impact factor: 3.416

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.